{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:54:18Z","timestamp":1694753658309},"reference-count":26,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T00:00:00Z","timestamp":1203552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p>Many coronary patients on antiplatelet (PLT) drugs require coronary artery bypass grafting surgery under conditions that may not allow sufficient time for or warrant discontinuation of anti\u2010PLT treatment. Recent clinical data show that intraoperative aprotinin significantly reduces postoperative bleeding and transfusion requirements in this patient population. If surgical bleeding persists, the administration of Factor VIIa should be considered.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2007.01576.x","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T17:45:32Z","timestamp":1203615932000},"source":"Crossref","is-referenced-by-count":1,"title":["Novel antithrombotic agents and the risk of bleeding"],"prefix":"10.1111","volume":"48","author":[{"given":"Jan","family":"Van Der Linden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,21]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443140-00002"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2411"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000138790.14877.7D"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01954-X"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.02.019"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200112000-00006"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.03.028"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00020-5"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.09.046"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050522"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.03.041"},{"key":"e_1_2_3_14_2","article-title":"Anti\u2010fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"1","author":"Henry DA","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051379"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0265021506001955"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020798"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.681395"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aem252"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957020-00015"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)01337-5"},{"key":"e_1_2_3_22_2","first-page":"554","article-title":"Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations","volume":"107","author":"Murkin JM","year":"1994","journal-title":"J\u2003Thorac Cardiovasc Surg"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(93)90117-7"},{"key":"e_1_2_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.03.079"},{"issue":"9","key":"e_1_2_3_25_2","first-page":"I276","article-title":"Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double\u2010blind, placebo\u2010controlled, randomized clinical trial","volume":"112","author":"Van Der Linden J","year":"2005","journal-title":"Circulation"},{"key":"e_1_2_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.01.009"},{"key":"e_1_2_3_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.11.013"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2007.01576.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2007.01576.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T05:14:30Z","timestamp":1694668470000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2007.01576.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,21]]},"references-count":26,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1537-2995.2007.01576.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01576.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,21]]}}}